Eden Research (EDEN) Stock Overview
Engages in the development and sale of biopesticides in Europe and the United Kingdom. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
EDEN Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Eden Research plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.027 |
| 52 Week High | UK£0.046 |
| 52 Week Low | UK£0.02 |
| Beta | 1.63 |
| 1 Month Change | 28.57% |
| 3 Month Change | 0% |
| 1 Year Change | -31.65% |
| 3 Year Change | -43.16% |
| 5 Year Change | -78.40% |
| Change since IPO | -99.57% |
Recent News & Updates
Recent updates
We Think Eden Research (LON:EDEN) Can Afford To Drive Business Growth
Aug 25
We Think Eden Research (LON:EDEN) Needs To Drive Business Growth Carefully
Jul 09We're Keeping An Eye On Eden Research's (LON:EDEN) Cash Burn Rate
Mar 05We Think Eden Research (LON:EDEN) Needs To Drive Business Growth Carefully
Nov 06Companies Like Eden Research (LON:EDEN) Are In A Position To Invest In Growth
Jul 07We're Hopeful That Eden Research (LON:EDEN) Will Use Its Cash Wisely
Feb 18
A Look At Eden Research's (LON:EDEN) Share Price Returns
Dec 25We're Hopeful That Eden Research (LON:EDEN) Will Use Its Cash Wisely
Nov 19Shareholder Returns
| EDEN | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 0% | -0.3% | -0.03% |
| 1Y | -31.6% | 0.1% | 20.5% |
Return vs Industry: EDEN underperformed the UK Chemicals industry which returned 0.1% over the past year.
Return vs Market: EDEN underperformed the UK Market which returned 20.5% over the past year.
Price Volatility
| EDEN volatility | |
|---|---|
| EDEN Average Weekly Movement | 7.7% |
| Chemicals Industry Average Movement | 6.4% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.8% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: EDEN's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: EDEN's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 23 | Sean Smith | www.edenresearch.com |
Eden Research plc, together with its subsidiaries, engages in the development and sale of biopesticides in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consume products, such as head-lice treatment, deodorants, odour neutralizer, and fragrances, as well as food flavourings and active ingredients; and animal health products comprising companion animal, bio-control, parasite treatments, and insect sprays.
Eden Research plc Fundamentals Summary
| EDEN fundamental statistics | |
|---|---|
| Market cap | UK£14.40m |
| Earnings (TTM) | -UK£2.35m |
| Revenue (TTM) | UK£3.62m |
Is EDEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EDEN income statement (TTM) | |
|---|---|
| Revenue | UK£3.62m |
| Cost of Revenue | UK£1.74m |
| Gross Profit | UK£1.87m |
| Other Expenses | UK£4.22m |
| Earnings | -UK£2.35m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0044 |
| Gross Margin | 51.81% |
| Net Profit Margin | -65.01% |
| Debt/Equity Ratio | 0% |
How did EDEN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/29 06:22 |
| End of Day Share Price | 2025/12/24 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Eden Research plc is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andrew Murray Darley | Cavendish |
| Christopher Donnellan | Cavendish |
| Yvette Riachi | Hardman & Co. |